DAVITA INC. (DVA)
Health Care / Health Care Services
S&P 500$227.93
Above average across most dimensions. A solid candidate.
Strong Buy
Score based on 5 of 5 models — high confidence
Is DAVITA INC. a Good Investment in 2026?
DAVITA INC. (DVA) scores 7.7 out of 10 on AlphaStocks' composite model, earning a Strong Buy rating. The Piotroski model rates DAVITA INC. as Attractive (6/9). The Lynch model is the least favorable, rating it Neutral. DAVITA INC. currently trades below its estimated fair value of $264, suggesting potential upside. DAVITA INC. ranks #19 out of 1123 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading near or slightly below estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
6/9
Buffett
Attractive
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Neutral
PEG 1.9 · Stalwart
Greenblatt
Attractive
Top 25% (rank 17%)
Frequently Asked Questions
Is DAVITA INC. (DVA) a good investment?
What is DAVITA INC.'s Piotroski F-Score?
Is DVA overvalued or undervalued?
How does DVA compare to other Health Care stocks?
What do investment models say about DVA?
Similar Stocks
Compare DVA with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer